Navigation Links
Breaking Down Barriers: A Woman's Path to Reducing HIV Stigma in the Arab American Community
Date:2/20/2008

eling and/or medical tests. She talks with them about safe sex practices, HIV, and STI testing options. "The biggest challenges," says Dinah, "are getting women to talk about HIV and getting them tested. Many women don't want to get tested - at least not before they come back to the clinic a few times."

In 2005, women represented 26% of new AIDS diagnoses, compared to only 11% of new AIDS cases reported in 1990. Due to the increase of HIV/AIDS in women and girls, the Federal government instituted "National Women and Girls HIV/AIDS Awareness Day," held each year on March 10. Its efforts align with ACCESS': encouraging discussions among women about HIV prevention, testing, and care.

Since many of Dinah's clients are mothers she emphasizes to them the importance of talking with their children about HIV. "There are few things as powerful as the mother to child bond," says Dinah, "Mothers can play a critical role in educating their children about health risks and safe practices."

ACCESS' Public Health Team incorporates discussions about HIV into most medical screenings. The Centers for Disease Control and Prevention (CDC) recommends voluntary HIV testing during routine medical and prenatal visits for all people ages 13 to 64. Dinah is passionate about making this a reality for Arab Americans.

Dinah is a trusted resource in the community. As one of her clients stated, "Dinah really put me on the right track." Much of her success stems from helping women realize that knowing their HIV status and educating their children about HIV, is first and foremost a matter of health.

To learn more about:

http://www.accesscommunity.org

http://www.hivtest.org

http://www.AIDS.gov


'/>"/>
SOURCE Arab Community Center for Economic and Social Services
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery
2. CleanRest(R) Announces a Groundbreaking Invention, The Worlds Cleanest Pillow(TM)
3. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
4. Breaking down Huntingtons disease one protein at a time
5. California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program
6. Ground Breaking Program Improves Diabetes Patient Outcomes
7. Official Ground Breaking Ceremony for Cleveland Clinic Abu Dhabi
8. On The Go Ships 100TB Hardware Order for Ground-Breaking Cancer Imaging and Therapy Projects
9. VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series
10. Record-Breaking Financial Recovery Made in UnitedHealth Backdating Case
11. Breaking Studies at AARC Congress Show Masimo SET and Masimo Rainbow SET to be Accurate, Effective and Uniquely Beneficial in Detecting and Tracking Disease States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... This December, and on the eve of its 35t...HC) will launch an integrated Season of Giving mar...help goes a long way. The initiative, designed to ...s for the Charity and its three core programs: Ron...d the Ronald McDonald Care Mobile. , ...
(Date:12/4/2008)...Toy Safety Program Offers Manufacturers A Way to I... the NewConsumer Product Safety Improvement Act ,...wswire/ -- Recent toy recalls continue to generate...r children,s toys, reinforcing the importance of t...ion -- integrated services that include auditing, ...
(Date:12/4/2008)...on available in global compliance and ethics onlin...-USNewswire/ -- The Society of Corporate Complianc... Association (HCCA) announced today the associatio... to all compliance and ethics professionals beginn... the social network sites and participate in the o...
(Date:12/4/2008)...th Care Brought Closer to More Veterans , , ...erans will have easier access to world-class healt... plan to open 31 new outpatient clinics in 16 stat... James B. Peake today announced VA will establish ...ida, Georgia, Hawaii, Illinois, Iowa, Maryland, Mi...
Breaking Medicine News(10 mins):Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 3Health News:NSF International Offers Answers to Rising Toy Safety Concerns 2Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 2Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 3Health News:VA Opening 31 New Outpatient Clinics 2
...eye from a dead body kept at Bhilai Steel Plant (B... Saturday.// The incident that took place Friday ...m here. The deceased, 32-year-old C.H. Srinivas, w... last week after he met with a road accident. "So...
...me to the Brampton, Ont., Tim Horton's location ar...epatitis A.// According to health officials in Pe...n at 2 Intermodal Dr. has tested positive for hepa...cal officer of the health, Dr. Eileen De Villa, ha...
...at fibrin fibers could stretch to three times its ...ile some could even stretch to six times// their o...n blood clotting is developed in the blood from a ...injury occurs fibrin is deposited around the wound...
... denied admission to a medical college here becaus...7 percent disability, has urged President// A.P.J.... in the Scheduled Tribe category of the state join...ission to the VSS Medical College in Burla. The co...
Other Medicine News:
(Date:12/2/2008)...ratories, a leading clinical-diagnostics and biom...ogy and allergy assays, announced that it has laun...nts whose immune systems may be compromised due to... drugs, or because they are taking immuno-suppress...e company launched the two new assays, the T Cell...
(Date:12/2/2008)...Therapeutics, Inc., a,privately held biopharmaceu...hase 3 trials evaluating its lead investigational ...ints. HZT-501, a novel, proprietary fixed-dose,co...ine, demonstrated a,statistically significant red...lammatory drug (NSAID)-induced upper gastrointesti...
(Date:12/1/2008)...w research has found that the availability of a po...r in an emergency room can significantly increase ...ally life-saving treatment. Results of the study, ...em Hospital in Salem, Mass., will be presented tod...ty of North America (RSNA). , , "The hospit...
(Date:12/1/2008)... -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) r...ld,s leading medical journals, results of clinical...ntal compound tasimelteon (VEC-162). The publicat...agonist tasimelteon (VEC-162) for transient insomn...ed multicentre trials." Results are reported from ...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Law Offices of Howard G Smith Announces Investigation on Behalf of Current and Former Employees of Merck 26 Co Inc Who Invested in the Merck 26 16441 1Haemacure Reports on its annual general and special meeting of shareholders 16438 1Haemacure Reports on its annual general and special meeting of shareholders 16438 2Haemacure Reports on its annual general and special meeting of shareholders 16438 3Haemacure Reports on its annual general and special meeting of shareholders 16438 4Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 16435 1Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 16435 2Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 16435 3Vanishing polar ice talk to be Webcast live April 10 2838 1
..., Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- N...logical and,pharmacokinetic profiles of Basilea,s ...role and isavuconazole. Studies reported,both for ...ephalosporin in late-stage development, and for is...vasive fungal infections,yielded further data on ...
... France, April 04, 2007 /PRNewswire/ -- Novagali P...ny specialized in,ophthalmology, announces today p...of Vekacia(R) in children suffering from Vernal,Ke...it was shown,that both symptoms and signs of disea...hermore, the tolerability to Vekacia(R),was excell...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
Performa cemented stem.
Porous foundation 470 series.
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications.
The link classic plus hip stem for cemented primary hip replacement surgery
Medicine Products: